Economic Modeling of The Use of Botulinum Toxin A in A Homogenous Patient Population Based on Real-Life Clinical Practice: Ulis-Ii (The Upper Limb International Spasticity Study)
Value Health. 2014 Nov;17(7):A377.
doi: 10.1016/j.jval.2014.08.2596.
Epub 2014 Oct 26.